Technology

The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.

A study published in JAMA Network Open found that increased EHR use among primary care physicians was associated with improved patient A1c levels, hypertension control and breast cancer screening rates.

The multinational pharma company will now be able to access Tempus' de-identified patient data.

The deal comes about a week after GE announced new details about its plans to spin off its healthcare unit.

Calm Health, offered through providers, payers and self-insured employers, builds off the company's acquisition of Ripple Health Group.

The company will use the funds to expand its platform and accelerate global commercialization.

According to reporting by TechCrunch, the company laid off around 500 employees.

David Rosen, a partner and public policy lawyer at Foley & Lardner, discusses the agency's recently wrapped Software Precertification Pilot Program and what it means for the future of digital health regulation.

Also, Max Life in India has developed an analytics solution that detects inaccurate medical reports in real time.

The company also announced a partnership with pharma giant Biogen that allows providers to submit enrollment forms for its multiple sclerosis drug Vumerity through the new platform.